These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 25851098)

  • 21. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control.
    Nicolau J; Rivera R; Francés C; Chacártegui B; Masmiquel L
    Diabetes Res Clin Pract; 2013 Aug; 101(2):148-52. PubMed ID: 23800573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bipolar disorders, type 2 diabetes mellitus, and the brain.
    Hajek T; McIntyre R; Alda M
    Curr Opin Psychiatry; 2016 Jan; 29(1):1-6. PubMed ID: 26575297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Relationship Between Food Insecurity and Depression, Diabetes Distress and Medication Adherence Among Low-Income Patients with Poorly-Controlled Diabetes.
    Silverman J; Krieger J; Kiefer M; Hebert P; Robinson J; Nelson K
    J Gen Intern Med; 2015 Oct; 30(10):1476-80. PubMed ID: 25917659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
    Nadeau DA
    Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment response in type 2 diabetes patients with major depression.
    Gois C; Dias VV; Carmo I; Duarte R; Ferro A; Santos AL; Sousa F; Barbosa A
    Clin Psychol Psychother; 2014; 21(1):39-48. PubMed ID: 22962030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of depression and antidepressant use on goal setting and barrier identification among patients with type 2 diabetes.
    Chen HY; Ruppert K; Charron-Prochownik D; Noullet WV; Zgibor JC
    Diabetes Educ; 2011; 37(3):370-80. PubMed ID: 21460104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Depression and diabetes mellitus type 2].
    Deuschle M; Schweiger U
    Nervenarzt; 2012 Nov; 83(11):1410-22. PubMed ID: 23069895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and diabetes: treatment and health-care delivery.
    Petrak F; Baumeister H; Skinner TC; Brown A; Holt RIG
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):472-485. PubMed ID: 25995125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment.
    Musselman DL; Betan E; Larsen H; Phillips LS
    Biol Psychiatry; 2003 Aug; 54(3):317-29. PubMed ID: 12893107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Paneni F; Lüscher TF
    Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J
    Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New drugs for cancer, diabetes, dpression. Therapy à la genetic code].
    Neumaier J
    MMW Fortschr Med; 2003 May; 145(18):10. PubMed ID: 12808812
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter to the Editor - "longitudinal effects of depression and glycemic control in veterans with type 2 diabetes" by Richardson et al.
    Faulkner J
    Gen Hosp Psychiatry; 2009; 31(3):300. PubMed ID: 19410115
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
    Blonde L
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S4-11. PubMed ID: 19952303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential efficacy of cognitive behavioral therapy and psychodynamic therapy for major depression: a study of prescriptive factors.
    Driessen E; Smits N; Dekker JJ; Peen J; Don FJ; Kool S; Westra D; Hendriksen M; Cuijpers P; Van HL
    Psychol Med; 2016 Mar; 46(4):731-44. PubMed ID: 26750445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.